{"id":"https://openalex.org/W3016576844","doi":"https://doi.org/10.1111/bjh.16635","title":"Statin and cyclooxygenase\u20102 inhibitors improve survival in newly diagnosed diffuse large B\u2010cell lymphoma: a large population\u2010based study of 4913 subjects","display_name":"Statin and cyclooxygenase\u20102 inhibitors improve survival in newly diagnosed diffuse large B\u2010cell lymphoma: a large population\u2010based study of 4913 subjects","publication_year":2020,"publication_date":"2020-04-17","ids":{"openalex":"https://openalex.org/W3016576844","doi":"https://doi.org/10.1111/bjh.16635","mag":"3016576844","pmid":"https://pubmed.ncbi.nlm.nih.gov/32304100"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.16635","doi":"https://doi.org/10.1111/bjh.16635","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.16635","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082349971","display_name":"Liam Smyth","orcid":"https://orcid.org/0000-0002-2219-5780","observed_orcids":["https://orcid.org/0000-0002-2219-5780"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I4210115218","display_name":"St. Vincent's University Hospital","ror":"https://ror.org/029tkqm80","country_code":"IE","type":"healthcare","lineage":["https://openalex.org/I4210115218"]},{"id":"https://openalex.org/I4210167439","display_name":"Sunnybrook Hospital","ror":"https://ror.org/008kn1a71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4210167439"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA","IE"],"is_corresponding":true,"raw_author_name":"Liam Smyth","raw_affiliation_strings":["Department of Haematology, St. Vincent's University Hospital, Dublin, Ireland","Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"],"raw_orcid":"https://orcid.org/0000-0002-2219-5780","affiliations":[{"raw_affiliation_string":"Department of Haematology, St. Vincent's University Hospital, Dublin, Ireland","institution_ids":["https://openalex.org/I4210115218"]},{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027906208","display_name":"Danielle N. Blunt","orcid":"https://orcid.org/0009-0004-7398-1628","observed_orcids":["https://orcid.org/0009-0004-7398-1628"]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I4210167439","display_name":"Sunnybrook Hospital","ror":"https://ror.org/008kn1a71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4210167439"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["AU","CA"],"is_corresponding":false,"raw_author_name":"Danielle N. Blunt","raw_affiliation_strings":["Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia","Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia","institution_ids":["https://openalex.org/I1320133117"]},{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048610221","display_name":"Evgenia Gatov","orcid":"https://orcid.org/0000-0003-3173-2995","observed_orcids":["https://orcid.org/0000-0003-3173-2995"]},"institutions":[{"id":"https://openalex.org/I4210147079","display_name":"Institute for Clinical Evaluative Sciences","ror":"https://ror.org/05p6rhy72","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210147079"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Evgenia Gatov","raw_affiliation_strings":["ICES, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICES, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210147079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026076576","display_name":"Chenthila Nagamuthu","orcid":"https://orcid.org/0000-0003-1114-1645","observed_orcids":["https://orcid.org/0000-0003-1114-1645"]},"institutions":[{"id":"https://openalex.org/I4210147079","display_name":"Institute for Clinical Evaluative Sciences","ror":"https://ror.org/05p6rhy72","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210147079"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Chenthila Nagamuthu","raw_affiliation_strings":["ICES, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICES, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210147079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028935397","display_name":"Ruth Croxford","orcid":"https://orcid.org/0000-0002-6738-0402","observed_orcids":["https://orcid.org/0000-0002-6738-0402"]},"institutions":[{"id":"https://openalex.org/I4210147079","display_name":"Institute for Clinical Evaluative Sciences","ror":"https://ror.org/05p6rhy72","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210147079"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ruth Croxford","raw_affiliation_strings":["ICES, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICES, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210147079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076995401","display_name":"Lee Mozessohn","orcid":"https://orcid.org/0000-0003-3436-3849","observed_orcids":["https://orcid.org/0000-0003-3436-3849"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I4210167439","display_name":"Sunnybrook Hospital","ror":"https://ror.org/008kn1a71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4210167439"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Lee Mozessohn","raw_affiliation_strings":["Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024269299","display_name":"Matthew C. Cheung","orcid":"https://orcid.org/0000-0003-3193-5872","observed_orcids":["https://orcid.org/0000-0003-3193-5872"]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4210147079","display_name":"Institute for Clinical Evaluative Sciences","ror":"https://ror.org/05p6rhy72","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4210147079"]},{"id":"https://openalex.org/I4210167439","display_name":"Sunnybrook Hospital","ror":"https://ror.org/008kn1a71","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4210167439"]},{"id":"https://openalex.org/I4405271711","display_name":"Odette Cancer Centre","ror":"https://ror.org/02ww1s787","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004","https://openalex.org/I4405271711"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Matthew C. Cheung","raw_affiliation_strings":["Division of Hematology/Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON, Canada","ICES, Toronto, ON, Canada","Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"ICES, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210147079"]},{"raw_affiliation_string":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210167439","https://openalex.org/I4405271711"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5082349971"],"corresponding_institution_ids":["https://openalex.org/I1323843004","https://openalex.org/I4210115218","https://openalex.org/I4210167439","https://openalex.org/I4405271711"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":4.9965,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.9618838,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"191","issue":"3","first_page":"396","last_page":"404"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9559999704360962},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9909999966621399},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.6179999709129333},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.6439999938011169},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.9120000004768372},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.4740000069141388},{"id":"https://openalex.org/keywords/newly-diagnosed-lymphoma","display_name":"newly diagnosed lymphoma","score":0.7239999771118164},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.5580000281333923},{"id":"https://openalex.org/keywords/transformed-lymphoma","display_name":"transformed lymphoma","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.687379002571106},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.680736243724823},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6513596177101135},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6454676389694214},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5335650444030762},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4849741458892822},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47233548760414124},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3788643181324005},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11537289619445801},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.09427374601364136},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009026","descriptor_name":"Mortality","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011159","descriptor_name":"Population Surveillance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/bjh.16635","doi":"https://doi.org/10.1111/bjh.16635","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bjh.16635","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:32304100","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32304100","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320319966","display_name":"Ontario Ministry of Health and Long-Term Care","ror":"https://ror.org/00tjpb250"},{"id":"https://openalex.org/F4320334745","display_name":"Institute of Chemical and Engineering Sciences","ror":"https://ror.org/01cbwn720"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1593721960","https://openalex.org/W1970516397","https://openalex.org/W1971403921","https://openalex.org/W2000314277","https://openalex.org/W2006661877","https://openalex.org/W2020789296","https://openalex.org/W2026656096","https://openalex.org/W2040608814","https://openalex.org/W2046616137","https://openalex.org/W2060844658","https://openalex.org/W2073210502","https://openalex.org/W2083075461","https://openalex.org/W2084648638","https://openalex.org/W2128518863","https://openalex.org/W2129083387","https://openalex.org/W2136060045","https://openalex.org/W2152012720","https://openalex.org/W2154736427","https://openalex.org/W2158058326","https://openalex.org/W2158731007","https://openalex.org/W2171848487","https://openalex.org/W2418491101","https://openalex.org/W2528279704","https://openalex.org/W2536558537","https://openalex.org/W2787311961","https://openalex.org/W2947781658","https://openalex.org/W4234118229"],"related_works":["https://openalex.org/W2989439927","https://openalex.org/W7204693124","https://openalex.org/W7204709725","https://openalex.org/W4288843959","https://openalex.org/W2171848487","https://openalex.org/W2000314277","https://openalex.org/W2152012720","https://openalex.org/W3032105861","https://openalex.org/W4283366956","https://openalex.org/W2551406920"],"abstract_inverted_index":{"Preclinical":[0],"data":[1],"suggests":[2],"anti-lymphoma":[3],"potential":[4],"for":[5,67,129,147,178,224],"statins,":[6,120],"metformin":[7],"and":[8,42,70,78,95,123,134,166,174,193,218],"cyclooxygenase-2":[9],"(COX-2)":[10],"inhibitors.":[11],"We":[12],"performed":[13],"a":[14,36,99,125,142,210],"retrospective":[15],"population-based":[16,207],"study":[17,208],"of":[18,54,101,214],"all":[19],"adults":[20],"aged":[21],"\u226566":[22],"years":[23],"diagnosed":[24,226],"with":[25,35,86],"diffuse":[26],"large":[27],"B-cell":[28],"lymphoma":[29,33,61],"(DLBCL)":[30],"or":[31],"transformed":[32],"treated":[34,85],"rituximab":[37],"containing":[38],"regimen,":[39],"between":[40,75],"2005":[41],"2015":[43],"in":[44],"Ontario,":[45],"Canada.":[46],"Using":[47],"administrative":[48],"databases,":[49],"we":[50],"assessed":[51],"the":[52,73,112],"impact":[53],"medication":[55,76],"exposures,":[56],"prior":[57,114,137,221],"to":[58,109,115,132,138,216,222],"chemo-immunotherapy,":[59],"on":[60],"survival.":[62,79],"Cox":[63],"regression":[64],"analyses,":[65],"controlling":[66],"sociodemographic":[68],"factors":[69],"comorbidities,":[71],"examined":[72],"relationship":[74],"exposure":[77,131,146,177,215],"In":[80,111],"total,":[81],"4913":[82],"patients":[83],"were":[84],"curative":[87],"intent":[88],"(median":[89],"age":[90],"75":[91],"years,":[92],"51%":[93],"male)":[94],"52\u00b72%":[96],"died":[97],"at":[98],"median":[100],"1":[102],"year":[103,113],"from":[104],"treatment":[105],"initiation":[106],"(67%":[107],"due":[108],"DLBCL).":[110],"commencing":[116],"treatment,":[117],"45\u00b77%":[118],"received":[119],"16\u00b73%":[121],"metformin,":[122],"25\u00b70%":[124],"COX-2":[126,135,175,219],"inhibitor.":[127],"Adjusting":[128],"confounders,":[130],"statin":[133,145],"inhibitors":[136,220],"chemo-immunotherapy":[139,223],"independently":[140],"conferred":[141],"survival":[143,212],"advantage:":[144],"30":[148,179],"days":[149,160,168,180,187,195],"(hazard":[150],"ratio":[151],"[HR]":[152],"0\u00b797,":[153],"95%":[154,163,171,183,190,198],"confidence":[155],"interval":[156],"[CI]":[157],"0\u00b796-0\u00b798),":[158],"180":[159,186],"(HR":[161,169,181,188,196],"0\u00b784,":[162],"CI":[164,172,184,191,199],"0\u00b780-0\u00b789)":[165],"365":[167,194],"0\u00b771,":[170],"0\u00b763-0\u00b779)":[173],"inhibitor":[176],"0\u00b795,":[182],"0\u00b795-0\u00b798),":[185],"0\u00b776,":[189],"0\u00b766-0\u00b786)":[192],"0\u00b757,":[197],"0\u00b743-0\u00b774).":[200],"Metformin":[201],"had":[202],"no":[203],"significant":[204],"impact.":[205],"This":[206],"found":[209],"dose-related":[211],"benefit":[213],"statins":[217],"newly":[225],"DLBCL.":[227]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-04-24T00:00:00"}